Haemonetics Corporation   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Braintree MA United States (1971)
Status: No NME R&D (1971)

Organization Overview

First Clinical Trial
2004
NCT00998088
First Marketed Drug
2004
sodium chloride
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

HAEMONETICS